You'd look at our initial motion and then come back with questions of clarification and look for direction and suggestions to help narrow down the study and be more focused.
In response to Mr. Carrie's comments, people are paying for those drugs right now on the private sector side. They're paying through employer-based plans or they're paying through their own private insurance that they're purchasing. If we move to a national formulary without increasing costs to private employers or increasing costs to the people who are currently buying private insurance, we would be able to transfer some of that spending to offset the cost of this program to government. Is that spend something you can estimate and collect data on?
We wouldn't increase costs to employers, but at the same time we recognize that they're already paying something here that can be captured and used to sponsor a national program.